Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2025).
Gross margin
€ 4.4 million
▲ 49% vs 2024
Profit
Growing€ 259,601
▲ 135% vs 2024
Debts
Normal€ 4.1 million
▼ 36% vs 2024
S-Biomedic from Gent, company number BE0668407105, closed financial year 2025 with a result of € 259,601 after tax. For that financial year S-Biomedic recorded a gross margin of € 4.4 million and equity of € 1.9 million. Compared with financial year 2024, the result moved from € -750,941 to € 259,601. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
What happened at S-Biomedic?
What happened at S-Biomedic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dr. Gitta Neufang stepped down as director. NBB
- Christopher Sheldon stepped down as director. NBB
- Dr. Stefan Gallinat stepped down as director. NBB
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- Dr. Gitta Neufang became a director. NBB
- Christopher Sheldon became a director. NBB
- Dr. Stefan Gallinat became a director. NBB
- New establishment in Gent. KBO
In short
From € 633,446 loss in 2021 to € 259,601 profit in 2025.
Best year ever: 2025, with € 259,601 profit.
On average € 364,600 of value added per employee in 2025.
A new publication or filing at S-Biomedic? We notify you, reason included.
Follow S-BiomedicNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Dr. Gitta Neufang
Director
since 2022 · until 2028
Christopher Sheldon
Director
since 2022 · until 2028
Dr. Stefan Gallinat
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
ORIONIS BIOSCIENCES
€ 11.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
272BIO
€ 104,252 gross margin · 2025
+11 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
SQUARESPACE - Squarespace, Inc., US
DNS
GoDaddy DNS
Domain
Domain
sbiomedic.com
Registered
2014-06-23
Registrar
Mesh Digital Limited
Expires
2026-06-23
Website info
Features
Security
Network
Details
- Company number
- 0668.407.105
- VAT number
- BE 0668.407.105
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- S-Biomedic
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2016
- Peppol
- Active · Active since 2 Dec 2025
- Contact
- sbiomedic.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Markt- en opinieonderzoek